These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29521025)

  • 1. Functional outcome measures for infantile Charcot-Marie-Tooth disease: a systematic review.
    Mandarakas MR; Rose KJ; Sanmaneechai O; Menezes MP; Refshauge KM; Burns J
    J Peripher Nerv Syst; 2018 Jun; 23(2):99-107. PubMed ID: 29521025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of the Charcot-Marie-Tooth Disease Infant Scale.
    Mandarakas MR; Menezes MP; Rose KJ; Shy R; Eichinger K; Foscan M; Estilow T; Kennedy R; Herbert K; Bray P; Refshauge K; Ryan MM; Yiu EM; Farrar M; Sampaio H; Moroni I; Pagliano E; Pareyson D; Yum SW; Herrmann DN; Acsadi G; Shy ME; Burns J; Sanmaneechai O
    Brain; 2018 Dec; 141(12):3319-3330. PubMed ID: 30476010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of the Pediatric Charcot-Marie-Tooth Disease Quality of Life Outcome Measure.
    Ramchandren S; Wu TT; Finkel RS; Siskind CE; Feely SME; Burns J; Reilly MM; Estilow T; Shy ME;
    Ann Neurol; 2021 Feb; 89(2):369-379. PubMed ID: 33222249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic Variability of Childhood Charcot-Marie-Tooth Disease.
    Cornett KM; Menezes MP; Bray P; Halaki M; Shy RR; Yum SW; Estilow T; Moroni I; Foscan M; Pagliano E; Pareyson D; Laurá M; Bhandari T; Muntoni F; Reilly MM; Finkel RS; Sowden J; Eichinger KJ; Herrmann DN; Shy ME; Burns J;
    JAMA Neurol; 2016 Jun; 73(6):645-51. PubMed ID: 27043305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Italian version of the Charcot-Marie-Tooth Health Index.
    Pisciotta C; Ciafaloni E; Zuccarino R; Calabrese D; Saveri P; Fenu S; Tramacere I; Genovese F; Dilek N; Johnson NE; Heatwole C; Herrmann DN; Pareyson D;
    J Peripher Nerv Syst; 2020 Sep; 25(3):292-296. PubMed ID: 32511835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter Validation of the Charcot-Marie-Tooth Functional Outcome Measure.
    Mandarakas MR; Eichinger KJ; Bray P; Cornett KMD; Shy ME; Reilly MM; Ramdharry GM; Scherer SS; Pareyson D; Estilow T; McKay MJ; ; Herrmann DN; Burns J
    Neurology; 2024 Feb; 102(3):e207963. PubMed ID: 38237108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.
    Berciano J; García A; Gallardo E; Peeters K; Pelayo-Negro AL; Álvarez-Paradelo S; Gazulla J; Martínez-Tames M; Infante J; Jordanova A
    J Neurol; 2017 Aug; 264(8):1655-1677. PubMed ID: 28364294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients.
    Mannil M; Solari A; Leha A; Pelayo-Negro AL; Berciano J; Schlotter-Weigel B; Walter MC; Rautenstrauss B; Schnizer TJ; Schenone A; Seeman P; Kadian C; Schreiber O; Angarita NG; Fabrizi GM; Gemignani F; Padua L; Santoro L; Quattrone A; Vita G; Calabrese D; ; Young P; Laurà M; Haberlová J; Mazanec R; Paulus W; Beissbarth T; Shy ME; Reilly MM; Pareyson D; Sereda MW
    Neuromuscul Disord; 2014 Nov; 24(11):1003-17. PubMed ID: 25085517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of the Charcot-Marie-Tooth functional outcome measure.
    Bray P; Cornett KMD; Estilow T; Pareyson D; Zuccarino R; Skorupinska M; Pipis M; Sowden JE; Scherer S; Reilly MM; Shy ME; Herrmann DN; Burns J; Eichinger KJ
    J Peripher Nerv Syst; 2020 Sep; 25(3):288-291. PubMed ID: 32844461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disability.
    Burns J; Ouvrier R; Estilow T; Shy R; Laurá M; Pallant JF; Lek M; Muntoni F; Reilly MM; Pareyson D; Acsadi G; Shy ME; Finkel RS
    Ann Neurol; 2012 May; 71(5):642-52. PubMed ID: 22522479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of exercise for Charcot-Marie-Tooth disease.
    Sman AD; Hackett D; Fiatarone Singh M; Fornusek C; Menezes MP; Burns J
    J Peripher Nerv Syst; 2015 Dec; 20(4):347-62. PubMed ID: 26010435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment for Charcot-Marie-Tooth disease.
    Young P; De Jonghe P; Stögbauer F; Butterfass-Bahloul T
    Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD006052. PubMed ID: 18254090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Charcot-Marie-Tooth Functional Outcome Measure (CMT-FOM).
    Eichinger K; Burns J; Cornett K; Bacon C; Shepherd ML; Mountain J; Sowden J; Shy R; Shy ME; Herrmann DN
    Neurology; 2018 Oct; 91(15):e1381-e1384. PubMed ID: 30232254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of clinical outcome measures in Charcot-Marie-Tooth disease.
    Solari A; Laurà M; Salsano E; Radice D; Pareyson D;
    Neuromuscul Disord; 2008 Jan; 18(1):19-26. PubMed ID: 17964785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Italian version of the Charcot-Marie-Tooth disease Pediatric Scale.
    Zuccarino R; Prada V; Moroni I; Pagliano E; Foscan M; Robbiano G; Pisciotta C; Cornett K; Shy R; Schenone A; Pareyson D; Shy M; Burns J
    J Peripher Nerv Syst; 2020 Jun; 25(2):138-142. PubMed ID: 32394473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease.
    Murphy SM; Herrmann DN; McDermott MP; Scherer SS; Shy ME; Reilly MM; Pareyson D
    J Peripher Nerv Syst; 2011 Sep; 16(3):191-8. PubMed ID: 22003934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel outcome measures for Charcot-Marie-Tooth disease: validation and reliability of the 6-min walk test and StepWatch(™) Activity Monitor and identification of the walking features related to higher quality of life.
    Padua L; Pazzaglia C; Pareyson D; Schenone A; Aiello A; Fabrizi GM; Cavallaro T; Santoro L; Manganelli F; Gemignani F; Vitetta F; Quattrone A; Mazzeo A; Russo M; Vita G;
    Eur J Neurol; 2016 Aug; 23(8):1343-50. PubMed ID: 27160471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responsiveness of gait analysis parameters in a cohort of 71 CMT subjects.
    Lencioni T; Piscosquito G; Rabuffetti M; Bovi G; Di Sipio E; Diverio M; Moroni I; Padua L; Pagliano E; Schenone A; Pareyson D; Ferrarin M
    Neuromuscul Disord; 2017 Nov; 27(11):1029-1037. PubMed ID: 28844614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a functional outcome measure for riboflavin transporter deficiency.
    Fennessy JR; Donlevy GA; McKay MJ; Burns J; Cornett KMD; Menezes MP
    J Peripher Nerv Syst; 2024 Jun; 29(2):185-192. PubMed ID: 38445790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.